antipsychotic medication in the year were investigated for the prescribed medication and concomitant psychotropic medication. Results: A total of 91 children and adolescents (mean age 16.2 ± 2.2 years, 53 boys) received antipsychotic medication. Among the prescriptions, risperidone (n = 59, 35.3%) and aripiprazole (n = 34, 20.4%) were the two most frequently prescribed antipsychotics. Of 91 patients, 80 (87.9%) have prescribed with antipsychotic monopharmacy (mean 134.9 ± 11.1 day), 33 (36.3%) with bipharmacy (mean 136.9 ± 20.2 days), and 12 (13.2%) with polypharmacy (more than three antipsychotics) (mean 32.5 ± 7.3 days) in the year. Mood stabilizers (n=48, 52.7%), and antidepressants (n=35, 38.5%) were co-medicated in the year. Discussion: Our study shows the prescription pattern of antipsychotics for children and adolescents with schizophrenia in Korea. 
F37. CACNA1C HYPOFUNCTION IN KETAMINE-ACTIVATED BRAIN NETWORKS IMPAIRS
Background: Patients with schizophrenia exhibit negative symptoms that predict functional outcome. Understanding the mechanisms underlying these symptoms are important for developing novel therapeutic treatments. These negative symptoms can be grouped into experiential-(motivational) or expressive-(social) based behaviors testable in rodents. Increased incidences of schizophrenia have been reported with winter gestation, while antagonizing NMDA receptor function in adulthood has been used to model other symptoms of schizophrenia. These two approaches were used to determine mechanisms that may contribute to negative symptoms in schizophrenia and test potential therapeutics. Methods: Normal dam mice were housed in custom photoperiod chambers for one week under normal photoperiod conditions (12 hour light:12 hour dark) to allow for initial acclimation. Half of the photoperiod chambers were then shifted to a short active (SA) condition (19 hours light: 5 hours dark) with mating triads formed. After a two-week pairing, pregnant dams were single-housed. The resulting pups were reared under these photoperiod conditions until P28, at which time they were weaned by sex into tetrads and moved into a standard vivarium room under normal active (NA) photoperiod. Mice were trained to perform nose-poke responses in a five-choice operant chamber. Adult Long Evans rats were also trained in separate 5-choice chambers and repeatedly treated with phencyclidine (PCP). Motivational behavior was tested on a progressive ratio breakpoint (PRB). Social behavior of mice were also assessed using a 3-chocie social recognition paradigm. Background: Rodent models of maternal immune activation (MIA) are increasingly used as experimental tools to study neuronal and behavioral dysfunctions in relation to infection-mediated neurodevelopmental disorders such as schizophrenia and autism. One of the most widely used MIA models is based on gestational administration of poly(I:C) (= polyriboinosinic-polyribocytdilic acid), a synthetic analog of double-stranded RNA that induces a cytokine-associated viral-like acute phase response. The effects of poly(I:C)-induced MIA on phenotypic changes in the offspring are known to be influenced by various factors, including the precise prenatal timing, genetic background, and immune stimulus intensity. Thus far, however, it has been ignored whether differences in laboratory housing systems can similarly affect the outcomes of MIA models. Here, we examined this possibility by comparing poly(I:C)-based MIA in two housing systems that are commonly used in preclinical rodent research, namely the individually ventilated cage (IVC) and open cage (OC) systems. Methods: Pregnant C57BL6/N mice were kept in IVC or OC and treated with a low (1 mg/kg, i.v.) or high (5 mg/kg, i.v.) dose of poly(I:C), or with corresponding vehicle solution (pyrogen-free, sterile 0.9% NaCl; i.v.). MIA or control treatment was induced on gestation day (GD) 9 or 12, and the resulting offspring were raised and maintained in IVC or OC until adulthood for behavioral testing. An additional cohort of dams were used to assess the influence of the different caging systems on poly(I:C)-induced cytokine responses in the maternal plasma, placenta, and fetal brains 1 hr and 6 hrs post-treatment. Results: Maternal administration of poly(I:C) on GD9 caused a dose-dependent increase in spontaneous abortion in IVC but not in OC system, whereas MIA in IVC systems during a later gestational time-point (GD12) did not do so. Maternal and fetal pro-inflammatory cytokine responses to poly(I:C) were markedly higher in animals kept in IVC as compared to OC systems. The efficacy of MIA to induce long-term behavioral deficits was influenced by the different housing conditions, the dosing of poly(I:C), and the precise prenatal timing. Discussion: The present study identified the type of cage system as a novel factor that can confound the outcomes of MIA. Our findings thus urge the need to consider and report the kind of cages used in rodent MIA models. Providing this information seems pivotal to yield robust and reproducible results in these models.
